HealthQuill
Progress in slowing child mortality and stillbirth deaths has received a severe blow due to funding cuts and shortages, with 1.9 million children dying in 2023 on account of stillbirths.
Drugs Health Pharma

Funding cuts ‘severely’ bleeding UN’s child survival, stillbirth programs

HQ Team March 25, 2025: Progress in slowing child mortality and stillbirth deaths has received a severe blow due to global funding cuts.

Read More
Obesity is a health risk that needs to be tackled worldwide
Health Medical

Weight loss offers health benefits, even if pounds creep back: Study

Bharti Jayshankar March 24, 2025: University of Gothenburg researchers have uncovered a silver lining for those who struggle to maintain weight loss. According.

Read More
Nova Nordisk's Ozempic has changed he weight loss landscape
Drugs Pharma

Brazil’s pharma giant Hypera to launch generic Ozempic in 2026

Bharti Jayshankar March 24, 2025: Brazilian pharmaceutical giant Hypera announced plans to introduce a generic version of semaglutide—the active ingredient in Novo Nordisk’s.

Read More
depression
Health Research

Research exposes dangers of viral claims in TikTok’s ADHD postings

HQ Team March 22, 2025: Social media misinformation, especially regarding mental health issues, is a rising problem. Platforms like YouTube and TikTok attract.

Read More
Being popular means being louder. An actor, musician, sportsperson or politician opening up about his or her mental health is better heard than an ordinary individual.
Opinion

Lone wolf fallacy: How sigma masculinity became internet’s toxic inside joke

Aparna S March 21, 2025: There was a time when online debates about masculinity revolved entirely around “alpha” versus “beta” males. Alphas were.

Read More
AstraZeneca’s drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish drugmaker.
Pharma

AstraZeneca to invest $2.5 Billion in Beijing R&D hub, expands China presence

HQ Team March 21, 2025: AstraZeneca has announced a $2.5 billion investment in a new Beijing R&D center, partnerships with Harbour BioMed and.

Read More
US adults who will develop dementia every year will rise to one million in 2060 from 514,000 in 2020, according to a study published in Nature Medicine.
Health

Semaglutide may combat Alzheimer’s by reducing brain inflammation:Study

HQ Team March 21, 2025: A study from China adds to mounting evidence that semaglutide—a medication widely used for type 2 diabetes (Ozempic).

Read More
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Health Research

Scientists unveil PINK1 protein structure, paving way for Parkinson’s Disease therapies

HQ Team March 20, 2025: Scientists at the Walter and Eliza Hall Institute (WEHI, Australia) have uncovered the structure of the PINK1 protein.

Read More
Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.
Health Research

Key protein ArfGAP2 identified as driver of autoimmune diseases

HQ Team March 20, 2025: Researchers have identified a protein, ArfGAP2, that triggers harmful immune responses in autoimmune diseases, offering a novel target.

Read More
Eight people have died in Rwanda due to Marburg virus disease and 26 others were confirmed to be infected by the illness — the first such in the eastern-central African nation.
Drugs Research

Study uncovers protein’s dual role in sepsis, offering new treatment hope

HQ Team March 18, 2025: Sepsis, a life-threatening response to infection that triggers organ failure, claims over 11 million lives worldwide annually, according.

Read More